ITGAV and neoplasm: From the CCK-8 experiment, we found that overexpression of ITGAV obviously promoted tumor cell proliferation at 48 and 72 h after transfection, while knockdown of ITGAV markedly inhibited the proliferation of tumor cells (Figures 10A,B).